The Nanosonics (ASX:NAN) share price is soaring 9% on Tuesday

What could be giving Nanosonics shares a boost on Tuesday?

| More on:
A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nanosonics Ltd (ASX: NAN) share price is roaring upwards today despite no announcements from the company.

In afternoon trade, shares in the infection prevention company are up 8.63% to $6.04 apiece. Consequently, the Nanosonics share price is 26.8% away from its 52-week high of $8.25.

Could Nanosonics be a buy?

Although there is a lack of news regarding Nanosonics on Tuesday, a broker note was recently published on the healthcare company.

According to the analysts at Morgans, the Nanosonics share price could have more upside awaiting shareholders. Ostensibly, the team of analysts has placed an add rating on the Trophon manufacturer, while simultaneously cutting its price target to $6.97.

However, even with the reduced price target, this would suggest a further 15.4% upside to the Nanosonics share price. Perhaps investors are still absorbing this proposition on Tuesday, as the shares are bid higher.

Another viewpoint, the market might be paying more attention to shares primed for the nation's reopening after months of COVID-19 restrictions. Healthcare shares with exposure to elective surgery have struggled throughout the pandemic. On Wednesday last week, New South Wales Health announced the return of non-urgent elective surgery across Greater Sydney.

At the time, NSW health deputy secretary Wayne Jones stated: "Thanks to the extraordinarily high vaccination rates across the state and declining community transmission of COVID-19, patients can now have their non-urgent surgery."

Investors might be speculating over the potential for an increase in Nanosonics Trophon consumables following the return of elective surgeries.

Nanosonics share price snapshot

Nanosonics shares have been range-bound since late 2019. During this time, the company's shares have traded between $4.65 and approximately $8.00. As a result, Nanosonics' volatility is above the broader market average.

In addition, Nanosonics has returned 11.4% over the past year. Meanwhile, the S&P/ASX 200 Index (ASX: XJO) has outperformed the company, delivering a return of 21%.

In terms of valuation, the company currently trades on a price-to-earnings (P/E) ratio of 208 times based on the current Nanosonics share price.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Researchers and doctors with futuristic 3d hologram overlay for body anatomy or dna in hospital clinic.
Healthcare Shares

Why investors are watching this ASX healthcare stock

A fresh clinical update has been released.

Read more »

A Sonic Healthcare medical researcher wearing a white coat sits at her desk in a laboratory conducting a COVID-19 test
Healthcare Shares

This biotech is up more than 20% on new deal news

Revenue will flow under this global deal just announced.

Read more »

A male doctor and a woman in scrubs in the foreground smile.
Healthcare Shares

The next 3 years could be huge for this ASX healthcare stock. Here's why

Today's update has put this ASX healthcare stock back in the spotlight as investors reassess its long-term growth potential.

Read more »

A doctor sits with a patient and uses a pen to point to certain parts of her mammogram scan
Healthcare Shares

Top broker says this ASX small-cap healthcare stock could be set to double

This company is making significant clinical and commercial progress .

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

3 quality ASX healthcare shares worth buying now

Brokers think the tide is turning for these battling medical heavyweights.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Early success in battling Crohn's Disease has sent this ASX biotech's shares soaring

The early-stage results have been described as outstanding.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

Why are 4DMedical shares in a trading halt today?

The company is looking to raise fresh capital.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX biotech's shares are up strongly on good news out of the US

The addressable market for this newly approved software is huge.

Read more »